The classic website will no longer be available as of June 25, 2024. Please use the modernized
Working… Menu

A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1) (CLARA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT06041256
Recruitment Status : Active, not recruiting
First Posted : September 18, 2023
Last Update Posted : June 10, 2024
Information provided by (Responsible Party):
Aurion Biotech

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : October 2024
Estimated Study Completion Date : October 2025